Sections
The AACR uses the power of collaboration to lead progress against cancer, convening key stakeholders from across the cancer research community and fostering the relationships needed to develop bold solutions to the most challenging aspects of the cancer problem.
In December, the AACR was selected as the recipient of an unrestricted donation that will transform the organization’s ability to advance its mission to prevent and cure all cancers. Pfizer Inc. announced that it had chosen to donate the rights of its royalties from the sale of Bavencio® (avelumab) in the United States to the AACR. The AACR was selected because of its sustained innovation in cancer research, and the donation will further advance cutting-edge science and accelerate the development of lifesaving discoveries against cancer.
In September, during a policy briefing to release the AACR Cancer Progress Report 2023, the AACR announced the launch of a major initiative that has the potential to accelerate the important work of the nation’s cancer centers. Under the leadership of AACR Past President (2021–2022) David A. Tuveson, MD, PhD, FAACR, the AACR Cancer Centers Alliance was formed to bring together the cancer centers with the goal of markedly expanding their scope and impact for the benefit of all patients with cancer. Ninety-four cancer centers signed on to become members of this new Alliance.
While its goals are broad-based and comprehensive, the Alliance—which was the result of a series of meetings of cancer center directors convened by the AACR beginning in 2022—will initially focus on four main areas of collaboration:
With its ability to identify and accelerate scientific priorities that will lead to lifesaving discoveries, the AACR is uniquely positioned to support the cancer centers’ goal to marshal their resources and collaborate directly, effectively, and synergistically to advance the nation’s cancer mission.
In July, with the support of its Pediatric Cancer Working Group, the AACR hosted two events focused on addressing the most critical challenges in pediatric cancer research:
From high school students to undergraduates to postgraduate researchers to independent investigators, the AACR sustains the pipeline of cancer scientists and clinicians. Under the leadership of chair Brian M. Rivers, PhD, MPH, the AACR Science Education and Career Advancement Committee ensures that the cancer workforce remains robust and ready to translate today’s discoveries into tomorrow’s treatments and cures.
More than 2,700 AACR members—five per cent of the total AACR membership—are high school students or undergraduates with an interest in cancer research. By tailoring programs for and offering professional development opportunities to this critical cohort, the AACR fosters the next generation of leaders in the cancer research community.
The AACR offered CME credit at 17 different meetings in 2023, including 14 conferences, one workshop, one joint providership meeting, and the AACR Annual Meeting 2023. AACR journals offered credit to investigators for reviewing manuscripts, and the AACR offered ten additional on-demand CME activities as part of the Project Livin’ Label series in partnership with the FDA. A total of 3,112 researchers and clinicians claimed CME credit from the AACR in 2023, and an additional 229 physicians obtained Medical Knowledge Maintenance of Certification (MOC) points through the American Board of Internal Medicine’s MOC program.
AACR meetings and educational workshops bring the latest advances in cancer science to researchers around the world. The AACR worked with 12 scientific organizations and institutions to convene 30 meetings and workshops in nine countries in 2023, exploring and advancing the frontiers of cutting-edge cancer science.
Those collaborations included a critical role in the most important breast cancer meeting in the world. The AACR has partnered with UT Health San Antonio since 2007 to develop the scientific program for the San Antonio Breast Cancer Symposium (SABCS). The partnership expanded in 2023, as the AACR took on increased responsibility for meeting logistics. With the AACR’s assistance, SABCS experienced record participation, with nearly 11,000 attendees from 102 countries and nearly 1,900 abstracts presented—including three late-breaking presentations of clinical trial results with practice-changing implications.
ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROME
AACR Special Conference in Cancer Research
January 23–25; Austin, Texas
Cochairs: Ravi Majeti, MD, PhD, Maria (Ken) Figueroa, MD, and Ruben A. Mesa, MD
TARGETING RAS
AACR Special Conference in Cancer Research
March 5–8; Philadelphia, Pennsylvania
Cochairs: Mariano Barbacid, PhD, FAACR, Dafna Bar–Sagi, PhD, FAACR, Frank McCormick, PhD, FAACR, and Deborah K. Morrison, PhD
DIGITAL AND COMPUTATIONAL PATHOLOGY: PRACTICE AND POSSIBILITIES
USCAP Companion Society Session
March 12; New Orleans, Louisiana
Cochairs: Faisal Mahmood, PhD, and Anil V. Parwani, MD, PhD
IMMUNE RESPONSES AND DNA REPAIR: CANCER FIELDS CONVERGING
EACR–AACR Basic and Translational Research Conference in partnership with SIC
March 15–17; Florence, Italy
Cochairs: Alberto Bardelli, PhD, Michael B. Kastan, MD, PhD, FAACR, and Nicola Normanno, MD
ADVANCES IN PROSTATE CANCER RESEARCH
AACR Special Conference in Cancer Research
March 15–18; Denver, Colorado
Cochairs: Cory Abate–Shen, PhD, Felix Y. Feng, MD, and Scott A. Tomlins, MD, PhD
AACR ANNUAL MEETING 2023
April 14–19; Orlando, Florida
Program Committee Chair: Robert H. Vonderheide, MD, DPhil
INTERNATIONAL CONFERENCE ON MALIGNANT LYMPHOMA (ICML)
June 13–17; Lugano, Switzerland
ICML President: Franco Cavalli, MD
Chair: Francesco Bertoni, MD
ADVANCES IN KIDNEY CANCER RESEARCH
AACR Special Conference in Cancer Research
June 24–27; Austin, Texas
Cochairs: Othon Iliopoulos, MD, M. Celeste Simon, PhD, FAACR, Cheryl Lyn Walker, MD, PhD, and Qing Zhang, PhD
SECOND JCA–AACR PRECISION CANCER MEDICINE INTERNATIONAL CONFERENCE
June 28–30; Kyoto, Japan
Cochairs: Hiroyoshi Nishikawa, MD, PhD, and Charles Swanton, MD, PhD, FAACR
AACR–AHNS HEAD AND NECK CANCER CONFERENCE
July 7–8; Montreal, Quebec, Canada
Cochairs: Joseph A. Califano, MD, Maura L. Gillison, MD, PhD, Sana D. Karam, MD, PhD, and Jose P. Zevallos, MD
CRI–ENCI–AACR SEVENTH INTERNATIONAL CANCER IMMUNOTHERAPY CONFERENCE: TRANSLATING SCIENCE INTO SURVIVAL
September 20–23; Milan, Italy
Cochairs: Pier Francesco Ferrucci, MD, PhD, Christoph Huber, MD, Arlene H. Sharpe, MD, PhD, FAACR, and Padmanee Sharma, MD, PhD
PANCREATIC CANCER
AACR Special Conference in Cancer Research
September 27–30; Boston, Massachusetts
Cochairs: Christine A. Iacobuzio–Donahue, MD, PhD, Anirban Maitra, MBBS, Rosalie C. Sears, PhD, and Jen Jen Yeh, MD
16TH AACR CONFERENCE ON THE SCIENCE OF CANCER HEALTH DISPARITIES IN RACIAL/ETHNIC MINORITIES AND THE MEDICALLY UNDERSERVED
September 29–October 2; Orlando, Florida
Cochairs: Ronny A. Bell, PhD, Gloria D. Coronado, PhD, Sophia H. L. George, PhD, Augusto C. Ochoa, MD, Renee Reams, PhD, and Tiffany A. Wallace, PhD
TUMOR IMMUNOLOGY AND IMMUNOTHERAPY
AACR Special Conference in Cancer Research in association with the Cancer Immunology (CIMM) Working Group
October 1–4; Toronto, Ontario, Canada
Cochairs: Philip D. Greenberg, MD, FAACR, Pamela S. Ohashi, PhD, Andrea Schietinger, PharmD, and Mario Sznol, MD
OVARIAN CANCER
AACR Special Conference in Cancer Research
October 5–7; Boston, Massachusetts
Cochairs: Frances R. Balkwill, PhD, Benjamin G. Neel, MD, PhD, Kunle Odunsi, MD, PhD, and Elizabeth M. Swisher, MD
AACR–NCI–EORTC INTERNATIONAL CONFERENCE ON MOLECULAR TARGETS AND CANCER THERAPEUTICS
October 11–15; Boston, Massachusetts
Cochairs: Timothy A. Yap, MD, PhD, Tim F. Greten, MD, and E.G. Elisabeth de Vries, MD, PhD
ADVANCES IN BREAST CANCER RESEARCH
AACR Special Conference in Cancer Research
October 19–22; San Diego, California
Cochairs: Jason S. Carroll, PhD, Jenny C. Chang, MD, and Jane E. Visvader, PhD, FAACR
BRAIN CANCER
AACR Special Conference in Cancer Research
October 19–22; Minneapolis, Minnesota
Cochairs: Nada Jabado, MD, PhD, Jeremy N. Rich, MD, and Michael D. Taylor, MD, PhD
AACR ON CAMPUS IN INDIA
in Partnership with The Advanced Centre for Treatment, Research, and Education in Cancer
October 31–November 1; Mumbai, India
FRONTIERS IN CANCER SCIENCE
Supported Meeting
November 6–8; Singapore
AACR–KCA JOINT CONFERENCE ON PRECISION MEDICINE IN CANCER
November 15–17; Seoul, Korea
Cochairs: Tae Min Kim, MD, PhD, and Elaine R. Mardis, PhD, FAACR
ENDOMETRIAL CANCER: TRANSFORMING CARE THROUGH SCIENCE
AACR Special Conference in Cancer Research
November 16–18; Boston, Massachusetts
Cochairs: Victoria L. Bae–Jump, MD, PhD, Deborah F. DeLair, MD, and Douglas A. Levine, MD
TRANSLATING CANCER EVOLUTION AND DATA SCIENCE: THE NEXT FRONTIER
AACR Special Conference in Cancer Research in association with the Cancer Evolution (CE) Working Group
December 3–6; Boston, Massachusetts
Cochairs: Anna D. Barker, PhD, FAACR, Franziska Michor, PhD, and Jeffrey P. Townsend, PhD
SAN ANTONIO BREAST CANCER SYMPOSIUM
UT Health San Antonio and AACR Joint Meeting
December 5–9; San Antonio, Texas
Codirectors: Carlos L. Arteaga, MD, FAACR, and Virginia G. Kaklamani, MD
EORTC–ESMO–AACR METHODS IN CLINICAL CANCER RESEARCH
June 17–23; Sint–Michielsgestel, Netherlands
Codirectors: Saskia Litiere, PhD, Nadia Harbek, MD, PhD, and Patricia M. LoRusso, DO, PhD (hc) FAACR
MOLECULAR BIOLOGY IN CLINICAL ONCOLOGY
July 16–22; Coronado, California
Director: Ross L. Levine, MD
Codirectors: Mark W. Geraci, MD, Christine M. Lovly, MD, PhD, and Jean Y. Tang, MD, PhD
ASCO/AACR METHODS IN CLINICAL CANCER RESEARCH
July 23–29; La Jolla, California
Codirectors: Julie M. Vose, MD, Manuel Hidalgo, MD, PhD, and Thomas M. Braun, PhD
INTEGRATIVE MOLECULAR EPIDEMIOLOGY: BRIDGING CANCER BIOLOGY AND PRECISION MEDICINE
July 24–28; Boston, Massachusetts
Codirectors: Peter Kraft, PhD, Lorelei A. Mucci, MPH, ScD, and Elizabeth A. Platz, MPH, ScD
TRANSLATIONAL CANCER RESEARCH FOR BASIC SCIENTISTS
November 12–17; Cambridge, Massachusetts
Codirectors: Ryan B. Corcoran, MD, PhD, and George D. Demetri, MD, FAACR
THE ROBERT A. WINN DIVERSITY IN CLINICAL TRIALS AWARD PROGRAM: BMSF–AACR DESIGN AND IMPLEMENTATION OF CLINICAL TRIALS WORKSHOP
November 15–19; La Jolla, California
Codirectors: Roy S. Herbst, MD, PhD, Priscilla E. Pemu, MD, Yu Shyr, PhD, FAACR, and Robert A. Winn, MD, FAACR